Medical Research Highlights — November 16, 2026 – Supplemental
Summary for November 16, 2026. oncology : breakthrough Current Sentiment: Strongly positive outlook A phase 3 trial of personalized mRNA cancer vaccines for melanoma showed 45% improved survival rates, led by Moderna and Merck at sites across the US and Europe, generating buzz on X and in Nature Med… Alternative view: High manufacturing costs may